Relevance of TNF-α, IL-6 and IRAK1 gene expression for assessing disease severity and therapy effects in tuberculosis patients

Introduction: Tuberculosis (TBC) is a contagious chronic respiratory disease which despite the known cause, Mycobacterium tuberculosis (Mtb), and many decades of successful therapy, remains one of the leading global health problems. Immune responses against Mtb infection involve both of types of im...

Full description

Saved in:
Bibliographic Details
Main Authors: Ivana Buha, Vesna Škodrić-Trifunović, Tatjana Adžić-Vukičević, Aleksandra Ilić, Ana Blanka-Protić, Mihailo Stjepanovic, Marina Anđelković, Miša Vreća, Jelena Milin-Lazović, Vesna Spasovski, Sonja Pavlović
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2019-05-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/10949
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850148815030452224
author Ivana Buha
Vesna Škodrić-Trifunović
Tatjana Adžić-Vukičević
Aleksandra Ilić
Ana Blanka-Protić
Mihailo Stjepanovic
Marina Anđelković
Miša Vreća
Jelena Milin-Lazović
Vesna Spasovski
Sonja Pavlović
author_facet Ivana Buha
Vesna Škodrić-Trifunović
Tatjana Adžić-Vukičević
Aleksandra Ilić
Ana Blanka-Protić
Mihailo Stjepanovic
Marina Anđelković
Miša Vreća
Jelena Milin-Lazović
Vesna Spasovski
Sonja Pavlović
author_sort Ivana Buha
collection DOAJ
description Introduction: Tuberculosis (TBC) is a contagious chronic respiratory disease which despite the known cause, Mycobacterium tuberculosis (Mtb), and many decades of successful therapy, remains one of the leading global health problems. Immune responses against Mtb infection involve both of types of immunity, but cellular immunity, in which certain cytokines and Th1 cells play a key role, is crucial. A better understanding of the functions of the cytokine network involved in the state and progression of TBC could identify specific molecular markers for monitoring of disease activity as well as therapy outcomes in TBC patients. Methodology: We investigated expression of TNF-α, IL-6 and IRAK1 genes using an RT-qPCR technique in peripheral blood mononuclear cells of 33 TBC patients and 10 healthy individuals. Results: Comparison between TBC patients and healthy individuals revealed statistically significant differences for all analyzed genes. The levels of expression of TNF-α and IL-6 mRNA were higher, while the level of IRAK1 mRNA was lower in the TBC group compared to controls. Moreover, a strong positive correlation was observed between TNF-α and IL-6 gene expression. When clinical parameters were analyzed, increased levels of TNF-α mRNA were detected in patients with a longer duration of therapy (>2 months) compared to those with a shorter therapy duration (< 2 months), and in patients without anemia. Conclusions: Our results indicate that the inflammatory genes we examined play a crucial role in the pathogenesis of tuberculosis, and that the expression of the TNF-α gene could be a marker for monitoring the clinical effect of the ant-tuberculosis drugs during therapy.
format Article
id doaj-art-abb34114cb8640f7afa5aee4de582a3e
institution OA Journals
issn 1972-2680
language English
publishDate 2019-05-01
publisher The Journal of Infection in Developing Countries
record_format Article
series Journal of Infection in Developing Countries
spelling doaj-art-abb34114cb8640f7afa5aee4de582a3e2025-08-20T02:27:09ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802019-05-01130510.3855/jidc.10949Relevance of TNF-α, IL-6 and IRAK1 gene expression for assessing disease severity and therapy effects in tuberculosis patientsIvana Buha0Vesna Škodrić-Trifunović1Tatjana Adžić-Vukičević2Aleksandra Ilić3Ana Blanka-Protić4Mihailo Stjepanovic5Marina Anđelković6Miša Vreća7Jelena Milin-Lazović8Vesna Spasovski9Sonja Pavlović10Clinic of Pulmonology, Clinical Centre of Serbia, Belgrade, SerbiaClinic of Pulmonology, Clinical Centre of Serbia, Belgrade, SerbiaClinic of Pulmonology, Clinical Centre of Serbia, Belgrade, SerbiaClinic of Pulmonology, Clinical Centre of Serbia, Belgrade, SerbiaClinic of Pulmonology, Clinical Centre of Serbia, Belgrade, SerbiaClinic of Pulmonology, Clinical Centre of Serbia, Belgrade, SerbiaInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, SerbiaInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, SerbiaSchool of Medicine, University of Belgrade, Belgrade, SerbiaInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, SerbiaInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia Introduction: Tuberculosis (TBC) is a contagious chronic respiratory disease which despite the known cause, Mycobacterium tuberculosis (Mtb), and many decades of successful therapy, remains one of the leading global health problems. Immune responses against Mtb infection involve both of types of immunity, but cellular immunity, in which certain cytokines and Th1 cells play a key role, is crucial. A better understanding of the functions of the cytokine network involved in the state and progression of TBC could identify specific molecular markers for monitoring of disease activity as well as therapy outcomes in TBC patients. Methodology: We investigated expression of TNF-α, IL-6 and IRAK1 genes using an RT-qPCR technique in peripheral blood mononuclear cells of 33 TBC patients and 10 healthy individuals. Results: Comparison between TBC patients and healthy individuals revealed statistically significant differences for all analyzed genes. The levels of expression of TNF-α and IL-6 mRNA were higher, while the level of IRAK1 mRNA was lower in the TBC group compared to controls. Moreover, a strong positive correlation was observed between TNF-α and IL-6 gene expression. When clinical parameters were analyzed, increased levels of TNF-α mRNA were detected in patients with a longer duration of therapy (>2 months) compared to those with a shorter therapy duration (< 2 months), and in patients without anemia. Conclusions: Our results indicate that the inflammatory genes we examined play a crucial role in the pathogenesis of tuberculosis, and that the expression of the TNF-α gene could be a marker for monitoring the clinical effect of the ant-tuberculosis drugs during therapy. https://jidc.org/index.php/journal/article/view/10949gene expressionmonitoring therapypulmonary tuberculosiscytokines
spellingShingle Ivana Buha
Vesna Škodrić-Trifunović
Tatjana Adžić-Vukičević
Aleksandra Ilić
Ana Blanka-Protić
Mihailo Stjepanovic
Marina Anđelković
Miša Vreća
Jelena Milin-Lazović
Vesna Spasovski
Sonja Pavlović
Relevance of TNF-α, IL-6 and IRAK1 gene expression for assessing disease severity and therapy effects in tuberculosis patients
Journal of Infection in Developing Countries
gene expression
monitoring therapy
pulmonary tuberculosis
cytokines
title Relevance of TNF-α, IL-6 and IRAK1 gene expression for assessing disease severity and therapy effects in tuberculosis patients
title_full Relevance of TNF-α, IL-6 and IRAK1 gene expression for assessing disease severity and therapy effects in tuberculosis patients
title_fullStr Relevance of TNF-α, IL-6 and IRAK1 gene expression for assessing disease severity and therapy effects in tuberculosis patients
title_full_unstemmed Relevance of TNF-α, IL-6 and IRAK1 gene expression for assessing disease severity and therapy effects in tuberculosis patients
title_short Relevance of TNF-α, IL-6 and IRAK1 gene expression for assessing disease severity and therapy effects in tuberculosis patients
title_sort relevance of tnf α il 6 and irak1 gene expression for assessing disease severity and therapy effects in tuberculosis patients
topic gene expression
monitoring therapy
pulmonary tuberculosis
cytokines
url https://jidc.org/index.php/journal/article/view/10949
work_keys_str_mv AT ivanabuha relevanceoftnfail6andirak1geneexpressionforassessingdiseaseseverityandtherapyeffectsintuberculosispatients
AT vesnaskodrictrifunovic relevanceoftnfail6andirak1geneexpressionforassessingdiseaseseverityandtherapyeffectsintuberculosispatients
AT tatjanaadzicvukicevic relevanceoftnfail6andirak1geneexpressionforassessingdiseaseseverityandtherapyeffectsintuberculosispatients
AT aleksandrailic relevanceoftnfail6andirak1geneexpressionforassessingdiseaseseverityandtherapyeffectsintuberculosispatients
AT anablankaprotic relevanceoftnfail6andirak1geneexpressionforassessingdiseaseseverityandtherapyeffectsintuberculosispatients
AT mihailostjepanovic relevanceoftnfail6andirak1geneexpressionforassessingdiseaseseverityandtherapyeffectsintuberculosispatients
AT marinaanđelkovic relevanceoftnfail6andirak1geneexpressionforassessingdiseaseseverityandtherapyeffectsintuberculosispatients
AT misavreca relevanceoftnfail6andirak1geneexpressionforassessingdiseaseseverityandtherapyeffectsintuberculosispatients
AT jelenamilinlazovic relevanceoftnfail6andirak1geneexpressionforassessingdiseaseseverityandtherapyeffectsintuberculosispatients
AT vesnaspasovski relevanceoftnfail6andirak1geneexpressionforassessingdiseaseseverityandtherapyeffectsintuberculosispatients
AT sonjapavlovic relevanceoftnfail6andirak1geneexpressionforassessingdiseaseseverityandtherapyeffectsintuberculosispatients